Skip to main content
INTI logo

INTI · Inhibitor Therapeutics, Inc. · Short Interest

Track INTI — free
$0.11 At close · Oct 16
Market Cap
$19.12M
Shares
173.79M
Volume · Oct 16 3900 Avg daily vol (3M) 15.6K

Shares sold short and not yet covered, reported twice monthly. Days to cover is the reported short position divided by average daily volume.

INTI Latest Reported Short Interest

FINRA reported 4,645 INTI shares sold short as of the July 31, 2026 settlement date, unchanged from the previous report. Days to cover was 1.00 based on FINRA's reported average daily volume.

Official FINRA short-interest data · share counts are restated for subsequent splits of this listing

Options positioning & squeeze sensitivity

Nearest expiration after today within 30 calendar days; same-day expirations and later maturities are excluded.

A complete options reference is unavailable.

Open interest has both a buyer and a seller; it does not reveal dealer hedge direction. Gross gamma sums both calls and puts without netting and uses a local 1% price-change approximation. It measures sensitivity, not predicted buying or a squeeze probability.

Assessment prepared 2026-10-21 10:31 UTC. Options model values may come from a cached snapshot; their original computation time is not supplied. Open interest has its own effective date.

Short Interest History

Settlement Date Current Position Previous Position Change Days to Cover
2026-10-30 Scheduled
FINRA publishes Nov 10
— — — —
2026-10-15 Scheduled
FINRA publishes Oct 26
— — — —
2026-07-31 4,645 4,645 0 1.00
2026-07-15 4,645 4,645 0 1.00
2026-06-30 4,645 11,804 -7,159 1.00
2026-06-15 11,804 17,846 -6,042 1.67
2026-05-29 17,846 17,114 +732 1.00
2026-05-15 17,114 0 +17,114 1.00
2026-04-15 632 22,435 -21,803 1.00
2026-03-31 22,435 23,934 -1,499 1.05
2026-03-13 23,934 13,144 +10,790 1.00
2026-02-27 13,144 12,256 +888 1.00
2026-02-13 12,256 1,756 +10,500 1.00
2026-01-30 1,756 54,032 -52,276 1.00
2026-01-15 54,032 0 +54,032 1.00

Full FINRA short interest reporting calendar

Showing 1–13 of 13 settlements
Key facts CIK 1042418 CUSIP 45720M105 Visit website Investor relations